The effect of the ovarian varicose vein on the DNA methylation in the rat’s oocyte

Document Type : Original Article


1 Department of Anatomy, Tehran University of Medical Sciences, Tehran, Iran

2 Department of Radiology, Shaheed Beheshti University of Medical Sciences, Tehran, Iran

3 ENT and Head & Neck Research Center and Department, Hazrat Rasoul Akram Hospital, Iran University of Medical Sciences (IUMS), Tehran, Iran

4 Department of Biotechnology, Shaheed Beheshti University of Medical Sciences, Tehran, Iran

5 Department of Anatomy, Kurdistan University of Medical Sciences, Sanandaj, Iran


Objective(s): We intended to determine whether the ovarian varicose which is one of the common etiologies of the pelvic congestion syndrome, has the ability to interfere with the DNA methylation reprogramming in the oocyte and thereby affect the oocyte quality or not.
Materials and Methods: Varicose model was induced according to the Turner’s method in the rats. Briefly, a 20-gauge needle was placed on the left renal vein and a thread was tied over both the needle and the renal vein medial to the insertion of the ovarian vein, and then the needle was removed. Evaluation of prooxidant-antioxidant balance (PAB) was assessed using specific kits and the expression level of the DNA methyltransferase genes Dnmt1, Dnmt3a and Dnmt3L was assessed by Real-time PCR. Immunofluorescent staining for 5-methylcytosine in the oocytes evaluated the global DNA methylation.
Results: A significant PAB increase in the ovaries from varicose group was seen. Real-time PCR demonstrated a remarkable decrease in the expression of the Dnmt3a and Dnmt3L which are responsible for de novo DNA methylation in the oocytes. Immunofluorescent staining for 5-mC showed a reduction in the fluorescence intensity in the oocytes collected from the varicose group.
Conclusion: Our findings from Real-time PCR and immunocytochemistry suggest that the epigenetic parameters in the oocyte could be affected by varicose induction and these epigenetic alteration has the potential to affect the oocyte quality. We suggest that the epigenetic changes could happen in the oocytes after the induction of ovarian varicose and lead to the oocyte quality reduction or even infertility.


1. Asciutto G, Asciutto K, Mumme A, Geier B. Pelvic venous incompetence: reflux patterns and treatment results. Eur J Vasc Endovasc Surg 2009; 38:381-386.
2. Jamieson DJ, Steege JF. The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices. Obstet Gynecol 1996; 87:55-58.
3. Nicholson T, Basile A. Pelvic congestion syndrome, who should we treat and how? Tech  Vasc Interv Radiol 2006; 9:19-23.
4. Beard R, Pearce S, Highman J, Reginald P. Diagnosis of pelvic varicosities in women with chronic pelvic pain. Lancet 1984; 324:946-949.
5. Chidekel N. Female pelvic veins demonstrated by selective renal phlebography with particular reference to pelvic varicosities. Acta Radiol Diagn 1968; 7:193-211.
6. Reginald P, Kooner J, Samarage S, Beard R, Mathias C, Sutherland I, et al. Intravenous dihydroergotamine to relieve pelvic congestion with pain in young women. Lancet 1987; 330:351-353.
7. Rastogi N, Kabutey NK, Kim D. Incapacitating pelvic congestion syndrome in a patient with a history of may–thurner Syndrome and left ovarian vein embolization. Ann Vasc Surg 2012; 26:732.
8. Yasim A, Kilinc M, Aral M, Oksuz H, Kabalci M, Eroglu E, et al. Serum concentration of procoagulant, endothelial and oxidative stress markers in early primary varicose veins. Phlebology 2008; 23:15-20.
9. Flore R, Santoliquido A, Antonio DL, Pola E, Flex A, Pola R, et al. Long saphenous vein stripping reduces local level of reactive oxygen metabolites in patients with varicose disease of the lower limbs. World J Surg 2003; 27:473-475.
10. Krzyściak W, Kózka M. Generation of reactive oxygen species by a sufficient, insufficient and varicose vein wall. Acta Biochim Pol 2011; 58:89-94.
11. Valko M, Rhodes C, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006; 160:1-40.
12. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 2004; 266:37-56.
13. Wachsman JT. DNA methylation and the association between genetic and epigenetic changes: relation to carcinogenesis. Mutat Res 1997; 375:1-8.
14. Turk PW, Laayoun A, Smith SS, Weitzman SA. DNA adduct 8-hydroxyl-2′-deoxyguanosine (8-hydroxyguanine) affects function of human DNA methyltransferase. Carcinogenesis 1995; 16:1253-1255.
15. Lim SO, Gu JM, Kim MS, Kim HS, Park YN, Park CK, et al. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Gastroenterology 2008; 135:2128-2140. e8.
16. Ferguson-Smith AC. Genomic imprinting: the emergence of an epigenetic paradigm. Nat Rev Genet 2011; 12:565-575.
17. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009; 462:315-322.
18. Kaneda M, Okano M, Hata K, Sado T, Tsujimoto N, Li E, et al. Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting. Nature 2004; 429:900-903.
19. Kaneda M, Hirasawa R, Chiba H, Okano M, Li E, Sasaki H. Genetic evidence for Dnmt3a‐dependent imprinting during oocyte growth obtained by conditional knockout with Zp3‐Cre and complete exclusion of Dnmt3b by chimera formation. Genes Cells 2010; 15:169-179.
20. Bourc'his D, Xu GL, Lin CS, Bollman B, Bestor TH. Dnmt3L and the establishment of maternal genomic imprints. Science 2001; 294:2536-2539.
21. Hata K, Okano M, Lei H, Li E. Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyltransferases to establish maternal imprints in mice. Development 2002; 129:1983-1993.
22. Turner T. The study of varicocele through the use of animal models. Hum Reprod Update 2001; 7:78-84.
23. Chuffa L, Amorim J, Teixeira G, Mendes L, Fioruci B, Pinheiro P, et al. Long-term melatonin treatment reduces ovarian mass and enhances tissue antioxidant defenses during ovulation in the rat. Braz J Med  Biol Res 2011; 44:217-223.
24. Hamidi Alamdari D, Ordoudi SA, Nenadis N, Tsimidou ZM, Koliakos G, Parizadeh SMR, et al. Comparison of prooxidant-antioxidant balance method with crocin method for determination of total prooxidant-antioxidant capacity. Iran J Basic Med Sci 2009; 12:93-99.
25. Messinger SM, Albertini DF. Centrosome and microtubule dynamics during meiotic progression in the mouse oocyte. J Cell Sci 1991; 100:289-298.
26. Richet A. Traité pratique d'anatomie médico-chirurgicale: F. Chamerot, Libraire-Éditeur; 1857.
27. Galkin E, Grakova L, Naumova E. Roentgeno-endovascular surgery of hypofunctional ovaries in varicosities of the ovarian veins. Vestn Rentgenol Radiol 1990;51-59.
28. Weight S, Bell P, Nicholson M. Renal ischaemia-reperfusion injury. Br J Surg 1996; 83:162-167.
29. Smith R, Kaune H, Parodi D, Madariaga M, Ríos R, Morales I, et al. Increased sperm DNA damage in patients with varicocele: relationship with seminal oxidative stress. Hum Reprod 2006; 21:986-993.
30. Hendin BN, Kolettis PN, Sharma RK, Thomas AJ, Agarwal A. Varicocele is associated with elevated spermatozoal reactive oxygen species production and diminished seminal plasma antioxidant capacity.  J Urol 1999; 161:1831-1834.
31. Heydari L, Mugahi SMHN, Fazelipour S, Koruji M, Alizadeh R, Abbasi N, et al. Efectos de las venas ováricas varicosas sobre la estructura mitocondrial, niveles de malondialdehído y balance prooxidantes: antioxidantes en ovarios de ratas. Int J Morphol 2015; 33:930-935.
32. Kehinde BA, Abolhassani F, Yazdekhasti H, Abbasi N, Heydari L, Daneshi E, et al. The effects of unilateral varicose ovarian vein on antioxidant capacity and oocyte quality in rat ovary. Iran J Basic Med Sci 2016; 19:863.
33. Laprise SL. Implications of epigenetics and genomic imprinting in assisted reproductive technologies. Mol Reprod Dev 2009; 76:1006-1018.